4//SEC Filing
Chambers Michael Andrew 4
Accession 0001193125-25-326980
CIK 0000873303other
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 4:40 PM ET
Size
9.6 KB
Accession
0001193125-25-326980
Insider Transaction Report
Form 4
Chambers Michael Andrew
Director
Transactions
- Disposition to Issuer
Convertible Senior Notes
2025-12-18(indirect: By Trust)Exercise: $141.97→ Common Stock (140,875 underlying) - Award
Convertible Senior Notes
2025-12-18(indirect: By Trust)Exercise: $60.00→ Common Stock (333,333 underlying)
Footnotes (3)
- [F1]On December 10, 2025, the Reporting Person and the Company entered into an exchange agreement related to the exchange by the Reporting Person of $20,000,000 in aggregate principal amount of the Company's 1.25% Convertible Senior Notes due 2027 (the "2027 Notes") for a combination of (i) $20,000,000 in aggregate principal amount of the Company's 4.875% Convertible Senior Notes due 2030 (the "2030 Notes") and (ii) $2,170,006.66 in cash in a private exchange with the Company. The exchange closed on December 18, 2025.
- [F2]The 2027 Notes are convertible at the election of the holder at any time prior to the close of business on the business day immediately preceding March 15, 2027, provided that certain convertibility conditions are met. On or after March 15, 2027 until the close of business on the second scheduled trading day immediately preceding the maturity date (September 15, 2027), holders may convert their notes at any time, regardless of the foregoing circumstances. Any conversion of the 2027 Notes may be settled in shares of Common Stock, cash or a combination of cash and shares of Common Stock at the Company's election.
- [F3]The 2030 Notes are convertible at the election of the holder at any time prior to the close of business on the business day immediately preceding March 1, 2030, provided that certain convertibility conditions are met. On or after March 1, 2030 until the close of business on the second scheduled trading day immediately preceding the maturity date (August 29, 2030), holders may convert their notes at any time, regardless of the foregoing circumstances. Any conversion of the 2030 Notes may be settled in shares of Common Stock, cash or a combination of cash and shares of Common Stock at the Company's election.
Documents
Issuer
Sarepta Therapeutics, Inc.
CIK 0000873303
Entity typeother
Related Parties
1- filerCIK 0001932527
Filing Metadata
- Form type
- 4
- Filed
- Dec 18, 7:00 PM ET
- Accepted
- Dec 19, 4:40 PM ET
- Size
- 9.6 KB